First quarter of 2016 in brief
· Order intake declined by 3.7% to SEK 6,924 M (7,192). The order intake
declined organically by 2.0%.
· Net sales fell by 5.0% to SEK 6,377 M (6,712). Net sales fell organically by
3.2%.
· The gross margin increased to 47.2% (46.8).
· EBITA* fell by 13.5% to SEK 620 M (717).
· Restructuring and integration costs amounted to SEK 127 M (183).
· Profit before tax amounted to SEK 157 M (146), corresponding to an increase
of 7.5%.
· Earnings per share amounted to SEK 0.46 (0.38).
· Good cost control – adjusted for exchange-rate effects, administrative and
selling expenses declined by 4.4%.
· Cash conversion from operating activities amounted to 75.5% (69.8).
· The transformation program is progressing according to plan and efficiency
initiatives are starting to generate results.
· New reporting structure for the Group with three new reporting segments
based on the three Business Category Units Surgical Workflows, Acute Care
Therapies and Patient & Post-Acute Care.
FINANCIAL SUMMARY
MSEK Jan-Mar 2016 Jan-Mar 2015 Change Rolling 12M
FY 2015
%
Order 6 924 7 192 -3.7% 30 163
30 431
intake
Net sales 6 377 6 712 -5.0% 29 900
30 235
Gross 3 011 3 142 -4.2% 14 032
14 163
Profit
Gross 47.2% 46.8% 0.4% 46.9%
46.8%
margin
EBITA* 620 717 -13.5% 4 082
4 179
EBITA 9.7% 10.7% -1.0% 13.7%
13.8%
margin*
Operating 316 335 -5.7% 2 710
2 729
profit
Profit 157 146 7.5% 2 008
1 997
before tax
Net profit 115 107 7.5% 1 465
1 457
Earnings 21.1%
per 0.46 0.38 5.91
5.83
share, SEK
Cash flow 7.0%
from 700 654 3 504
3 458
operations
* before restructuring, acquisition and integration cost
Getinge Interim Report January-March 2016
| Source: Getinge AB
Attachments
